Literature DB >> 24917735

Significance of ureteroscopic biopsy grade in patients with upper tract urothelial carcinoma.

Junya Furukawa1, Hideaki Miyake1, Iori Sakai1, Masato Fujisawa1.   

Abstract

BACKGROUND: The objective of this study was to assess the significance of the ureteroscopic biopsy grade for patients with upper tract urothelial carcinoma (UTUC). PATIENTS AND METHODS: This study included 40 patients who were diagnosed with a single focus of UTUC by ureteroscopic biopsy and subsequently underwent nephroureterectomy. The significance of the biopsy grade as a predictive factor for pathological outcomes of nephroureterectomy was retrospectively analyzed.
RESULTS: Of these 40 patients, 19 (47.5%) and 21 (52.5%) were diagnosed with low and high grade UTUC, respectively. The ureteroscopic biopsy grade matched the pathological grade of surgically resected specimens in 35 of the 40 cases (87.5%), and there was a significant correlation between the biopsy and pathological grades (p < 0.001). Furthermore, the biopsy grade was also shown to be closely associated with the pathological stage (p < 0.001); that is, only 1 of the 19 patients (5.3%) with biopsy low grade UTUC were pathologically diagnosed as having muscle invasive disease, while 17 of the 21 patients (81.0%) with biopsy high grade UTUC appeared to show tumor invasion into muscle or deeper.
CONCLUSIONS: The grade of UTUC on ureteroscopic biopsy could provide accurate diagnostic information on the final pathology of nephroureterectomy specimens.

Entities:  

Keywords:  Upper tract urothelial carcinoma; Ureteroscopic biopsy; Urinary cytology

Year:  2012        PMID: 24917735      PMCID: PMC3783279          DOI: 10.1159/000343531

Source DB:  PubMed          Journal:  Curr Urol        ISSN: 1661-7649


  14 in total

1.  Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscle-invasive and non-organ confined disease in patients with upper tract urothelial carcinoma.

Authors:  Ricardo L Favaretto; Shahrokh F Shariat; Caroline Savage; Guilherme Godoy; Daher C Chade; Matthew Kaag; Bernard H Bochner; Jonathan Coleman; Guido Dalbagni
Journal:  BJU Int       Date:  2011-06-01       Impact factor: 5.588

2.  CD24 expression in urothelial carcinoma of the upper urinary tract correlates with tumour progression.

Authors:  Alexandra Winkler; Richard Zigeuner; Peter Rehak; Georg Hutterer; Thomas Chromecki; Cord Langner
Journal:  Virchows Arch       Date:  2006-11-17       Impact factor: 4.064

3.  Expression profile of E-cadherin and N-cadherin in urothelial carcinoma of the upper urinary tract is associated with disease recurrence in patients undergoing nephroureterectomy.

Authors:  Mototsugu Muramaki; Hideaki Miyake; Tomoaki Terakawa; Yuji Kusuda; Masato Fujisawa
Journal:  Urology       Date:  2011-09-15       Impact factor: 2.649

Review 4.  Prognostic factors for upper urinary tract urothelial carcinoma.

Authors:  Thomas F Chromecki; Karim Bensalah; Mesut Remzi; Grégory Verhoest; Eugene K Cha; Douglas S Scherr; Giacomo Novara; Pierre I Karakiewicz; Shahrokh F Shariat
Journal:  Nat Rev Urol       Date:  2011-07-05       Impact factor: 14.432

5.  Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tract.

Authors:  Vitaly Margulis; Ramy F Youssef; Pierre I Karakiewicz; Yair Lotan; Christopher G Wood; Richard Zigeuner; Eiji Kikuchi; Alon Weizer; Jay D Raman; Mesut Remzi; Marco Roscigno; Francesco Montorsi; Christian Bolenz; Wassim Kassouf; Shahrokh F Shariat
Journal:  J Urol       Date:  2010-06-17       Impact factor: 7.450

6.  Ureteropyeloscopic diagnosis and treatment of upper urinary tract urothelial malignancies.

Authors:  M Grasso; M Fraiman; M Levine
Journal:  Urology       Date:  1999-08       Impact factor: 2.649

7.  Endourologic management of patients with upper-tract transitional-cell carcinoma: long-term follow-up in a single center.

Authors:  Steven J Sowter; Cristian P Ilie; Ioannis Efthimiou; David A Tolley
Journal:  J Endourol       Date:  2007-09       Impact factor: 2.942

8.  Endourological treatment of upper tract urothelial carcinomas: analysis of a series of 59 tumors.

Authors:  J A Martínez-Piñeiro; M J García Matres; L Martínez-Piñeiro
Journal:  J Urol       Date:  1996-08       Impact factor: 7.450

9.  Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration.

Authors:  Vitaly Margulis; Shahrokh F Shariat; Surena F Matin; Ashish M Kamat; Richard Zigeuner; Eiji Kikuchi; Yair Lotan; Alon Weizer; Jay D Raman; Christopher G Wood
Journal:  Cancer       Date:  2009-03-15       Impact factor: 6.860

10.  Endoscopic management of upper tract transitional cell carcinoma in patients with normal contralateral kidneys.

Authors:  R Houston Thompson; Amy E Krambeck; Christine M Lohse; Daniel S Elliott; David E Patterson; Michael L Blute
Journal:  Urology       Date:  2008-02-11       Impact factor: 2.649

View more
  2 in total

1.  Does lymph node dissection during nephroureterectomy affect oncological outcomes in upper tract urothelial carcinoma patients without suspicious lymph node metastasis on preoperative imaging studies?

Authors:  Sangjun Yoo; Dalsan You; In Gab Jeong; Bumsik Hong; Jun Hyuk Hong; Hanjong Ahn; Choung-Soo Kim
Journal:  World J Urol       Date:  2016-08-08       Impact factor: 4.226

2.  Intrarenal urothelial cancers confused as infiltrative renal masses: Report of 22 cases and literature review.

Authors:  Xiaobo Ding; Xiaobo Ma; Yatao Jia; Hongfei Li; Yanbo Wang
Journal:  Oncol Lett       Date:  2018-06-01       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.